Paola et al. report TNF-NFKB1 signalling pathway directly regulates CD47 by interacting with a constituent enhancer located within a CD47-associated SE specific to breast cancer, which drive CD47 overexpression to escape immune surveillance [11]. Here, CD47 is linked to breast cancer.